On April 1, 2020, the fee for filing a Certificate of Supplementary Protection (CSP) will increase from $9,376 to $9,564 in accordance with subsection 9(1) of the Certificate of Supplementary Protection Regulations (notice). For an update on the CSP regime, please see our previously published article here.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
2020 Highlights in Canadian Life Sciences IP and Regulatory Law
In 2020, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law.Read More -
First year of Project Orbis leads to 38 approvals of cancer therapies, including 8 by Health Canada
The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence recently published an overview of Project Orbis and the regulatory actions within the first year of its implementation (June 2...Read More -
Brexit prompts amendment to CSP Regulations
On December 21, 2020, the CSP Regulations were amended to add the U.K. as a “prescribed country” for the purpose of determining the timeliness of the CSP applicant’s New Drug Submission.Read More